コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bercular treatment and most of whom were HIV seropositive.
2 Mothers of 157 infants (83.5%) were CMV-seropositive.
3 n starting ART aged older than 24 weeks were seropositive.
4 uded, 209 (68%) of whom were cytomegalovirus seropositive.
5 One patient was dual seropositive.
6 Out of the 250 cases, 155 (62%) were seropositive.
7 All patients were Epstein-Barr virus IgG seropositive.
8 patients were female, and 42 (30%) were HIV seropositive.
9 serologically screened individuals, 26% were seropositive.
10 4 years (IQR: 27-44), and 130 (28%) were HIV seropositive.
11 12 years of chronological age for those CMV seropositive.
12 Two American robins were also seropositive.
13 were HCV seropositive; 26 (3.1%) were HTLV-1-seropositive.
15 2%; 95% confidence interval, 0.7%-4.3%) were seropositive, 3 with documented travel and 1 who had an
17 2.7 to 96.1) in the subcutaneous group, were seropositive, a difference of -9.2 percentage points (95
18 though individuals in all professions tested seropositive, abattoir workers (10 of 97; 10.3%) were si
19 8% in HIV-seronegative adults and 71% in HIV-seropositive adults (odds ratio, 6.2; 95% confidence int
20 frequency and quantity are high among HSV-2-seropositive adults in sub-Saharan Africa, including per
23 ys (November 10, 2016) that included 160 CMV-seropositive adults with either sepsis or trauma and res
27 IgG-seronegative patients who receive an IgG-seropositive allograft do not develop CMV infection desp
28 dies investigating the infectiousness of HIV-seropositive and -seronegative index cases have been per
30 717 of 974 (73.6%) household contacts of HIV-seropositive and -seronegative tuberculosis cases (relat
35 novel susceptibility factors for PTLD in EBV-seropositive and EBV-seronegative individuals, respectiv
36 ean follow-up of 8.2 years, we observed (HCV seropositive and HCV seronegative, respectively) 107 and
37 ng and immunohistochemical analyses of HIV-1 seropositive and HIV-1 encephalitic human brain tissues
38 the frequency of genital HSV shedding in HIV-seropositive and HIV-seronegative men and women in Ugand
39 an immunodeficiency virus (HIV)-infected HCV-seropositive and incidence density-matched HCV-seronegat
40 rum and longitudinal outcome in 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.
41 ngly, in both studies, immunization of HSV-1-seropositive animals had little effect on recurrent vagi
44 (+) T cells from HLA-A*02:01 positive, HSV-1 seropositive ASYMP and symptomatic (SYMP) individuals (w
45 ially studied HLA-A*02:01-positive and HSV-1-seropositive ASYMP individuals, the most frequent, robus
46 onors who were seropositive in 2005 remained seropositive at 5 years and maintained neutralizing anti
47 tion in 64% of all participants; among those seropositive at age 15-16 years, 84% were predicted to r
48 ldren in the subcutaneous group [94.7%] were seropositive at day 91, a difference of -9.3 percentage
51 d 3 HEV reinfections among patients who were seropositive before transplantation through detection of
54 ents carrying KIR2DS4*00101 alleles were CMV seropositive, but not control individuals, and exhibited
57 the head and neck cancer GWAS limited to HPV-seropositive cases and an independent cervical cancer GW
60 We here assess DS-Cav1 F immunogenicity in seropositive cattle pre-exposed to bovine RSV, a virus c
61 V-serostatus (11 [48%] of 23 symptomatic HIV-seropositive child contacts vs two [7%] of 31 asymptomat
62 contacts vs two [7%] of 31 asymptomatic HIV-seropositive child contacts) or to only culture-confirme
63 in 250 classic (non-AIDS) KS cases, 280 KSHV-seropositive controls, and 576 KSHV-seronegative control
65 7 of 12 (58.3%) seronegative recipients of a seropositive donor (positive donor/negative recipient [D
66 cially in patients receiving an organ from a seropositive donor (SHR, 1.92 [95% CI, 1.30-2.85]; P = .
68 ve patient, our data support selecting a CMV-seropositive donor if the patient receives a myeloablati
70 8-DNA was detected in 6.8% and 2.9% of HHV8-seropositive donor samples by in-house nested PCR and qu
71 , were cytomegalovirus seropositive or had a seropositive donor, and underwent weekly plasma cytomega
72 plant, 3 (25%) of 12 HHV8-mismatch patients (seropositive donor/seronegative recipient) developed a p
73 eronegative recipients receiving organs from seropositive donors (D+R-) and 104 seropositive recipien
76 e analysis, recipients receiving grafts from seropositive donors had a higher risk of chronic GVHD th
84 that approximately 31.4% of 433 horses were seropositive for antibodies (Abs) against NPHV and appro
85 g was positive for Eurasian H5 viral RNA and seropositive for antibodies reactive to the Eurasian H5
86 a patient with NMOSD whose test results were seropositive for aquaporin-4 IgG and who had a hepatic m
87 who had ataxia, were 18 years or older, were seropositive for at least 1 neural autoantibody, had rec
89 ttransplant: 78 (57%) of F-->M patients were seropositive for at least 1 of the 6 HY-Abs, and 3-month
91 9 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB
92 her in vaccinated than unvaccinated subjects seropositive for both antibody to hepatitis B surface an
95 G6 IgA seropositive individuals (59.1%) were seropositive for celiac disease-related alleles compared
97 ls are expanded in patients with AAV who are seropositive for cytomegalovirus (CMV), and are associat
98 nts with APECED lacked Paneth cells and were seropositive for defensin-specific autoantibodies; the p
102 e found in healthy ASYMP individuals who are seropositive for HSV-1 but never had any recurrent herpe
104 Among 2 047 740 first-time donors, 104 were seropositive for HTLV-1 (prevalence, 5.1 cases/per 100 0
105 idence interval [CI], 4.1-6.1), and 300 were seropositive for HTLV-2 (prevalence, 14.7 cases/per 100
106 presentation, 16% of patients with BMD were seropositive for IgG and/or IgM antibody to B. miyamotoi
107 ter vaccination, all vaccinated rabbits were seropositive for IgG to F. tularensis lipopolysaccharide
108 d distribution; proportions of US population seropositive for measles and rubella; and measles-mumps-
109 Equally high proportions of the samples were seropositive for measles virus, mumps virus, or rubella
112 We determined the proportion of females seropositive for PV antibody by 5-year age strata, and a
113 initial TNF inhibitor treatment in patients seropositive for rheumatoid arthritis and naive to treat
114 While 8 of the primatologists tested were seropositive for SFV from a NWM, the spider monkey, none
117 ak strain, 86.9% (95% CI, 75.8 to 94.2) were seropositive for the 44/76-SL strain, for which there wa
118 f these vaccinees (95% CI, 94.1 to 100) were seropositive for the 5/99 strain and had a higher geomet
121 nated and unvaccinated participants who were seropositive for the outbreak strain and for one closely
122 confidence interval [CI], 61.8 to 70.3) were seropositive for the outbreak strain, although the geome
124 e efficacy in herpes simplex virus 1 (HSV-1)-seropositive guinea pigs immunized and subsequently chal
127 y blood-derived T cells of 5 of 17 HSV-1/VZV-seropositive healthy adults but not in cord blood donors
128 t women, as well as CMV-seronegative and CMV-seropositive healthy adults, were included as controls.
129 le in the "natural" protection seen in HSV-1-seropositive healthy asymptomatic (ASYMP) individuals (w
130 y a role in the "natural" protection seen in seropositive healthy asymptomatic (ASYMP) individuals (w
133 dred fifty-six hepatitis B e antigen (HBeAg)-seropositive, hepatitis B surface antigen (HBsAg) carrie
134 nonuclear cell samples from 108 CMV- and EBV-seropositive HIV-infected men who have sex with men, who
135 are described in a prospective study of HCV-seropositive HIV-infected patients at Cipto Mangunkusomo
136 ose uptake by monocyte subpopulations in HIV-seropositive (HIV(+)) treatment-naive individuals (n = 1
137 d genital secretions were collected from HIV-seropositive (HIV+) Kenyan female sex workers (FSWs) (n
138 mononuclear cell (PBMC) samples from 107 CMV-seropositive, HIV-infected men who have sex with men, wh
142 ng-running community-recruited cohort of HIV-seropositive illicit drug users during a community-wide
146 sis contact investigation should include HIV-seropositive index cases in high disease burden settings
148 e for P. jirovecii; however, most adults are seropositive, indicating natural immune priming to this
149 ecific HLA antigen alleles; 13 of 22 TG6 IgA seropositive individuals (59.1%) were seropositive for c
151 eas HLA-B8 was a risk factor for PTLD in EBV-seropositive individuals (OR = 3.29, 95% CI = 1.52-7.09)
153 responses seen with age but suggest that CMV-seropositive individuals differ in their natural exposur
155 responses were lower in P. falciparum lysate-seropositive individuals than in seronegative individual
157 te controllers (ECs) are a rare group of HIV seropositive individuals who are able to control viral r
158 pandemic health problem, and the majority of seropositive individuals will eventually progress to AID
160 frequencies in human cytomegalovirus (HCMV)-seropositive individuals, and these have been shown to h
168 Previously, we examined IgGs from 10 HSV-seropositive individuals; all neutralized virus and were
169 roup heterogeneity, suggesting a subgroup of seropositive-like cases within seronegative cases (PBUHM
172 fection and the first malaria episode (PfRH5-seropositive median: 71 days, PfRH5-seronegative median:
173 ions were observed for HPV 16 among baseline-seropositive men [adjusted HR, 1.37; 95% confidence inte
174 V 18 infection was significantly lower among seropositive men in the unadjusted model (HR, 0.22; 95%
175 titers of protective antibodies from highly seropositive mothers have not been studied in detail.
179 te race/ethnicity with highly active AQP4-ab-seropositive NMO (n = 6) and NMO spectrum disorder (n =
180 splants in which donor or recipient were CMV seropositive (non-D-/R-), compared with D- transplant or
182 The most frequent clinical presentation of seropositive OLM cases were unilateral reduced vision an
183 tigen using matched T cells and MCs from CMV-seropositive or CMV-seronegative donors, and for antigen
184 2007, and Feb 28, 2013, were cytomegalovirus seropositive or had a seropositive donor, and underwent
185 men on antiretroviral therapy who were HSV-2 seropositive or seronegative and HIV-uninfected controls
190 A undetectability were analyzed in 431 HBeAg-seropositive participants and 1,708 HBeAg-seronegative p
192 re included in the analytic sample (2278 HIV-seropositive participants contributed 20 477 visits and
193 Compared with HCV-negative controls, HCV-seropositive participants had an increased risk of liver
194 eview and meta-analysis was conducted of HIV-seropositive participants receiving ART compared with no
195 % to 27.7% (P < .001), and 48.4% of unlinked seropositive participants were linked to HIV care throug
199 fication products were obtained from 118 HCV-seropositive participants; subtypes 4k (in 47 participan
203 l therapy in immunocompetent cytomegalovirus seropositive patients admitted to the ICU with acute res
204 (null) cells were found predominantly in CMV-seropositive patients and expanded in the posttransplant
206 o the major CMV pp65 and IE-1 antigens in 15 seropositive patients at intermediate risk of CMV infect
207 cing lesions from 284 aquaporin-4 (AQP4)-IgG seropositive patients at Mayo Clinic from 1996 to 2014.
210 trospective review of the medical records of seropositive patients identified in the Mayo Clinic Neur
213 ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous co
214 utoantibodies against glutamatergic NMDAR in seropositive patients who cannot be clinically identifie
216 We assessed whether CD4+CD28- T cells in CMV seropositive patients with AAV are associated with arter
217 n strategy targeting an unselected cohort of seropositive patients with acute respiratory distress sy
218 gG serostatus was longitudinally assessed in seropositive patients with available serum samples and a
219 Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp
222 In the first study, 889 untreated anti-HCV-seropositive patients without HCC symptoms were followed
223 possible cause of neurodegeneration in HIV-1-seropositive patients, which engages the ability of p17
231 tion, but EBV DNAemia detection in low-risk (seropositive) patients has poor specificity as a biomark
232 NS3-1073 and NS5-2594 were expanded from HCV-seropositive persons by peptide stimulation in vitro or
236 IBV was detected in 3 nasal swabs from PRRSV-seropositive pigs by real-time reverse transcription-PCR
237 tected in 3 nasal swabs collected from PRRSV-seropositive pigs by real-time RT-PCR and sequencing.
240 of the TEMRA pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was asso
242 jor histocompatibility complex (MHC) in 2782 seropositive RA cases and 4315 controls of Asian descent
243 -trend = 0.004) increased risk of developing seropositive RA compared with those who consumed no suga
244 t soda, is associated with increased risk of seropositive RA in women, independent of other dietary a
247 Current dogma suggests risk is greatest in seropositive recipient (R+)/seronegative donor (D-) tran
249 time to onset of prophylaxis failure in CMV-seropositive recipients of allogeneic hematopoietic-cell
250 gans from seropositive donors (D+R-) and 104 seropositive recipients receiving antithymocyte globulin
255 each HY-Ab was associated with a persistent seropositive response throughout the posttransplant foll
256 table anti-B. pseudomallei antibody, whereas seropositive results among neighborhood contacts was 5%
257 riority trial enrolled patients with active, seropositive rheumatoid arthritis and an inadequate resp
259 e and the highly specific assays, 66 AQP4-Ab seropositive samples were used to establish the sensitiv
261 and outcomes did not differ significantly in seropositive, seronegative, and statin-associated cases.
265 immunogenicity subgroup of 1944 children had seropositive status for one or more dengue serotypes.
266 ation after cardiac death, hepatitis B and C seropositive status, cigarette use, diabetes, hypertensi
267 formance of a kidney biopsy, cytomegalovirus seropositive status, donation after cardiac death, hepat
269 al skin biopsy specimens obtained from HSV-2-seropositive subjects at the time of lesion onset up to
270 nd HLA indicated that the gut microbiomes of seropositive subjects differed from those of autoantibod
271 ression of IL-18Ralpha on NK cells from HCMV seropositive subjects do not fully explain these impaire
272 Bacteroides and Prevotella, respectively, in seropositive subjects with multiple versus one autoantib
273 age, CD4 and gender-matched HIV-infected CMV-seropositive subjects, and among 21 HIV-uninfected contr
274 he salivary microbial composition for 10 HIV-seropositive subjects, before and 6 months after highly
277 genome-wide epitopes were compared in HSV-1-seropositive symptomatic individuals (with a history of
279 immunoglobulin G antibody levels among those seropositive to CMV were also associated with shorter LT
284 Approximately 97% of the population was seropositive to tetanus and diphtheria as defined by a p
288 Seropositive patients receiving grafts from seropositive unrelated donors had improved overall survi
292 otent (Neut50 < 0.1 mug/ml) nAbs from a DENV-seropositive volunteer immunized with the tetravalent va
295 ring of a lung transplant recipient (A2, CMV seropositive) who received a HLA-B27 bilateral lung allo
298 iated with HPV-16/18 between seronegative vs seropositive women (15-25 years) in the control arm (DNA
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。